首页> 外文期刊>Daruha-yi Giyahi >Antidepressant activity of methanol stem bark extract of Ficus platyphylla Del (Moraceae) in mice
【24h】

Antidepressant activity of methanol stem bark extract of Ficus platyphylla Del (Moraceae) in mice

机译:白花榕甲醇茎皮提取物的抗抑郁活性

获取原文
           

摘要

Background &??Aim Depression is a heterogeneous mood disorder affecting both people in developing and developed countries. The drugs used in its management are associated with adverse effects and delayed response which compromise their therapeutic benefits. This makes it worthwhile to look for antidepressants plants with proven advantage and favourable benefit-to-risk ratio. Ficusplatyphylla is used traditionally in West Africa for the management of mental illnesses.The aim of this study was to evaluate the antidepressant potential of the methanol stem bark extract of F.platyphylla. Experimental Thin layer chromatographic finger prints of the extract was established.?? The oral median lethal dose of the extract was estimated using OECD 420 guidelines. Antidepressant activity of the extract at doses of 125-500 mg/kg was evaluated using tail suspension test (TST) and forced swim test (FST). The Effects of the extract on motor co-ordination deficit and locomotion were evaluated using beam walking assay (BWA) and open field test (OFT) respectively. Results and Discussion The chromatographic profile suggested the presence of steroids, tannins, flavonoids, alkaloids and saponins. The LD50 was found to be a?¥2000 mg/kg orally. The extract significantly (p0.01) and dose dependently (125, 250 and 500 mg/kg) decrease the duration immobility in the TST and FST. There is no significant increase in the number of lines crossed and on the number of foot slips in the OFT and BWA respectively. Industrial and Practical recommendations The methanol stem bark extract of F.platyphylla possesses antidepressant activity. The phytoconstituents found present in the plant assumed to be responsible for the activity can be characterized and isolated to serve as lead compounds in the treatment of depression.
机译:背景与目的抑郁症是一种异质性情绪障碍,会影响发展中国家和发达国家的人们。在其管理中使用的药物与不良反应和反应延迟有关,这损害了它们的治疗益处。因此,有必要寻找具有公认优势和有利的风险比的抗抑郁药。西非传统上使用榕叶榕来管理精神疾病。本研究的目的是评估桔梗甲醇茎皮提取物的抗抑郁潜力。建立提取物的实验薄层色谱指纹图谱。使用OECD 420指南估算提取物的口服中位致死剂量。使用尾部悬浮试验(TST)和强制游泳试验(FST)评估了125-500 mg / kg剂量提取物的抗抑郁活性。分别使用束步测定法(BWA)和开放视野试验(OFT)评估提取物对运动协调障碍和运动的影响。结果与讨论色谱分析表明存在类固醇,单宁,类黄酮,生物碱和皂苷。口服LD50为¥ 2000 mg / kg。提取物显着(p <0.01)和剂量依赖性(125、250和500 mg / kg)降低了TST和FST的持续时间。在OFT和BWA中,交叉的线数和滑行数没有明显增加。工业和实用建议白桦的甲醇茎皮提取物具有抗抑郁活性。在植物中发现的被认为是造成这种活性的植物成分可以被表征和分离,以作为治疗抑郁症的先导化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号